YMRC
BIO icon

Yorktown Management & Research Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Yorktown Management & Research Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,500
Closed -$320K – 482
2014
Q1 		$320K Hold
2,500
– – 0.06% 170
2013
Q4 		$309K Hold
2,500
– – 0.06% 172
2013
Q3 		$294K Hold
2,500
– – 0.06% 168
2013
Q2 		$281K Buy
+2,500
New +$293K 0.06% 158

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Yorktown Management & Research Company's BIO Position: Q2 2014 in Review

Yorktown Management & Research Company sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2014, closing a stake of 2,500 shares — an estimated $320K sold.

Yorktown Management & Research Company first reported a position in BIO in Q2 2013 and held it in 4 quarters. The position peaked at $320K in Q1 2014. 204 funds tracked by Wall St. Rank hold BIO as of Q2 2014.

  • Yorktown Management & Research Company reported no remaining Bio-Rad Laboratories Class A position as of Q2 2014 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,500 Bio-Rad Laboratories Class A shares in Q2 2014, an estimated $320K.
  • Yorktown Management & Research Company first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 4 quarters.
  • Yorktown Management & Research Company's Bio-Rad Laboratories Class A position peaked at $320K in Q1 2014.
  • 204 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2014.

Based on Yorktown Management & Research Company's 13F filing for Q2 2014, filed 23 Jul 2014.